Figure 3From: A plasmid toolkit for cloning chimeric cDNAs encoding customized fusion proteins into any Gateway destination expression vectorAdaptation of existing Gateway Destination vectors for the expression of fusion proteins. A. Construction of adapter vector pDONR221-R4-R3. A PCR product corresponding to the attR4-attR3-containing Gateway cassette in pDEST-R4-R3 was amplified with primers that provided flanking attB1 and attB2 sites. An inactivating mutation was introduced into the CAT gene (red X) in pDONR221 by site-directed mutagenesis so that ccdB-resistant E. coli transformed with this plasmid were sensitive to chloramphenicol (CamS). A BP-recombination reaction was set up between the amplified attR4-attR3 Gateway cassette and pDONR221_CamS to create pDONR221-R4-R3 (see details under methods). The att sites involved in the reaction are marked with blue squares. Selection with LB medium containing kanamycin and chloramphenicol (Kan/Cam) yielded colonies containing the recombined plasmid. B. Adaptation of destination expression vector pEF5/FRT/V5-DEST for MultiSite Gateway recombination reactions. The same inactivating mutation in the CAT gene as above (red X) was introduced into the commercially available single-site destination expression vector pEF5/FRT/V5-DEST to generate a Cam-sensitive version (pEF5/FRT/DEST-CamS). The mutant plasmid was subjected to an LR-recombination reaction with pDONR221-R4-R3 in order to replace its original Gateway cassette with the attR4-attR3 MultiSite recombination cassette in pDONR221-R4-R3 (endowed with a wild type CAT gene). The att sites involved in the reaction are marked with green squares. Selection of the colonies containing recombined pEF5/FRT/V5-DEST (pEF5/FRT/-DEST-R4-R3) was carried out with LB medium containing ampicillin and chloramphenicol (Amp/Cam). Only the features in the pEF5/FRT/V5-DEST plasmid map that are relevant for the reaction are shown.Back to article page